CClinicalTrials.gg
CompletedNCT00935181Updated Jul 8, 2009

Respiratory Muscle Stretching in Chronic Obstructive Pulmonary Disease (COPD)

A Phase 4 interventional study of respiratory muscle stretching in Chronic Obstructive Pulmonary Disease, sponsored by Faculdade Evangelica do Parana. Completed at 1 site in Brazil. Open to participants aged 40 Years to 75 Years. Per ClinicalTrials.gov, last updated 2009-07-08.

Sponsored by Faculdade Evangelica do Parana · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
26
Allocation
Randomized
Ages
40 Years to 75 Years
Sex
All
01

Study summary

Objective: The investigators studied the effects of respiratory muscle stretching in an 8-week pulmonary rehabilitation program. Methods: This was a simple-blind parallel controlled trial, conducted an out-patient clinic. Twenty six patients with COPD (mean age 68 ± 6 y, percent of predicted FEV1 47 ± 16) were randomized to either respiratory muscle stretching group plus exercise training (RMS), and exercise training group (Sham), in an 8-week exercise program that had 3 sessions per week. The investigators measured inspiratory and expiratory muscle strength (by maximal inspiratory and expiratory pressure - PIM and PEM), exercise capacity (by 6-minute walk distance), dyspnea and quality of life.

02

Conditions studied

  • Chronic Obstructive Pulmonary Disease

Keywords

  • COPD
  • diaphragm
  • muscle
  • stretching
  • exercises
  • dyspnea
  • respiratory muscle stretching
  • pulmonary rehabilitation
  • exercise training
  • improved exercise capacity, dyspnea, quality of life
03

In context

Lung Diseases

3,303 studies on the registry are indexed under Lung Diseases; 355 are open to participants now.

This study's enrollment of 26 is below the median of 72 across 2,118 interventional studies indexed under Lung Diseases.

Browse Lung Diseases studies →

Lead sponsor

Faculdade Evangelica do Parana is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Subjects between 40 and 75 years of age referred by a physician to the Pulmonary Rehabilitation Program
  • With a clinical and spirometric diagnosis of moderate to severe COPD according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD), in a stable condition (without exacerbations or infections for at least a month)
  • Former smokers

Exclusion criteria

Exclusion Criteria:

  • Patients with a known history of asthma, or severe and/or unstable heart disease
  • Any other pathological condition that could impair their physical activities
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
26 participants (actual)

Study arms

  • Experimental
    exercise training program

    The exercise training program consisted of three 90-minute sessions per week for eight weeks. Each session consisted of a stretching exercise, resistance that patients started at 70% of the initial one-repetition maximum (1RM: the maximum load which can be moved only once over the full range of motion without compensatory movements) in the first week (3x8 repetitions). Every week the load was increased by 5% of the 1RM, and endurance training (treadmill walking speed was set at 60% of the average speed obtained from the 6MWT (6MWTpeak) for 10 mins in the first week and was increased to 20 mins in week 8

    Behavioral: respiratory muscle stretching

Interventions

  • Behavioralrespiratory muscle stretching

    stretching exercises for respiratory muscles like diaphragm, pectoral, dorsalis etc

    Also known as: pulmonary rehabilitation

06

What researchers measure

Primary outcomes

  1. Inspiratory muscle strength

    Time frame: 2 hours

Secondary outcomes

  1. Exercise capacity

    Time frame: 2 hours

07

Study locations

1 site
  • Faculdade Evangelica do Paraná
    Curitiba, Paraná 80730-000, Brazil
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 8, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00935181
Lead sponsor
Faculdade Evangelica do Parana
First posted
Jul 8, 2009
Start date
Jan 2006
Primary completion
Dec 2006
Completion
Dec 2008
Last update
Jul 8, 2009

Study contacts

Silvia R. Valderramas, Ph.D
principal investigator · Faculdade Evangelica do Paraná

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion